QAEMAP
LIVE

Serial Number

79316608

Owner

MITSUI KNOWLEDGE INDUSTRY CO., LTD.

Attorney

Flavia Campbell

Filing Date

May 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

QAEMAP Trademark

Serial Number: 79316608 • Registration: 6835860

QAEMAP is a trademark filed by MITSUI KNOWLEDGE INDUSTRY CO., LTD. on May 24, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MITSUI KNOWLEDGE INDUSTRY CO., LTD. (8 trademarks)

2-5-1 Atago,

Entity Type: 03

Trademark Details

Filing Date

May 24, 2021

Registration Date

September 6, 2022

Published for Opposition

June 21, 2022

Goods & Services

Recorded and downloadable computer software for visualizing, analyzing, evaluating and assessing three-dimensional protein structure, which are used in drug discovery, scientific research, and scientific testing; recorded and downloadable application software for visualizing, analyzing, evaluating and assessing three-dimensional protein structure, which are used in drug discovery, scientific research, and scientific testing; recorded and downloadable computer software platforms for visualizing, analyzing, evaluating and assessing three-dimensional protein structure, which are used in drug discovery, scientific research, and scientific testing

Providing on-line non-downloadable computer software for visualizing, analyzing, evaluating and assessing three-dimensional protein structure, which are used in drug discovery, scientific research, and scientific testing; providing temporary use of web-based applications for visualizing, analyzing, evaluating and assessing three-dimensional protein structure, which are used in drug discovery, scientific research, and scientific testing; platform as a service (PaaS) featuring computer software platforms for visualizing, analyzing, evaluating and assessing three-dimensional protein structure, which are used in drug discovery, scientific research, and scientific testing; design, programming and maintenance of computer software for visualizing, analyzing, evaluating and assessing three-dimensional protein structure, which are used in drug discovery, scientific research, and scientific testing; design, programming and maintenance of application software for visualizing, analyzing, evaluating and assessing three-dimensional protein structure, which are used in drug discovery, scientific research, and scientific testing; design, programming and maintenance of computer software platforms for visualizing, analyzing, evaluating and assessing three-dimensional protein structure, which are used in drug discovery, scientific research, and scientific testing; cloud computing, namely, providing virtual computer systems and virtual computer environments through cloud computing, integration of private and public cloud computing environments; computer system analysis; database design and development; data mining; analysis of technical data, namely, protein structure analysis from X-ray crystallography data and cryo-electron microscopy data

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
May 28, 2026 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 4, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 9, 2022 FICS
FINAL DISPOSITION PROCESSED
Dec 9, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 6, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 6, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 6, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 21, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 21, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 1, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 28, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 28, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 28, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 28, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 1, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 31, 2022 TROA
REFUSAL PROCESSED BY IB
Mar 27, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 9, 2022 RFCS
REFUSAL PROCESSED BY MPU
Mar 8, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 10, 2022 RFCR
NON-FINAL ACTION WRITTEN
Feb 9, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 4, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 6, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 2, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 29, 2021 REPR